Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system

Journal of General Virology

Volumn 80, Issue 12, 1999, Pages 3257-3265

  Shintani, Yoshizumi ^a   Yotsuyanagi, Hiroshi ^a,b   Moriya, Kyoji ^a   Fujie, Hajime ^a   Tsutsumi, Takeya ^a   Kanegae, Yumi ^a   Kimura, Satoshi ^a   Saito, Izumu ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RECOMBINASE;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CLONE; CELL LINE; CELL STRAIN HEPG2; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; VIRUS GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032748493     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-12-3257     Document Type: Article

References (52)

1. Amundson, S. A., Myers, T. G. & Fornace, A. J., Jr (1998). Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17, 3287-3299.
2. Aufiero, B. & Schneider, R. J. (1990). The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO Journal 9, 497-504.
3. Avantaggiati, M. L., Balsano, C., Natoli, G., De Marzio, E., Will, H., Elfassi, E. & Levrero, M. (1992). The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors. Archives of Virology Supplementum 4, 57-61.
4. Balsano, C., Avantaggiati, M. L., Natoli, G., De Marzio, E., Will, H., Perricaudet, M. & Levrero, M. (1991). Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level. Biochemical and Biophysical Research Communications 176, 985-992.
5. Benn, J. & Schneider, R. J. (1994). Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proceedings of the National Academy of Sciences, USA 91, 10350-10354.
6. Benn, J. & Schneider, R. J. (1995). Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proceedings of the National Academy of Sciences, USA 92, 11215-11219.
7. Caselmann, W. H. (1995). Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. Journal of Hepatology 22, 34-37.
8. Cheong, J. H., Yi, M. K., Lin, Y. & Murakami, S. (1995). Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO Journal 14, 143-150.
9. Chirillo, P., Pagano, S., Natoli, G., Puri, P. L., Burgio, V. L., Balsano, C. & Levrero, M. (1997). The hepatitis B virus X gene induces p53-mediated programmed cell death. Proceedings of the National Academy of Sciences, USA 94, 8162-8167.
10. Cross, J. C., Wen, P. & Rutter, W. J. (1993). Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proceedings of the National Academy of Sciences, USA 90, 8078-8082.
11. Debbas, M. & White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Development 7, 546-554.
12. Evan, G. & Littlewood, T. (1998). A matter of life and cell death. Science 281, 1317-1322.
13. Feitelson, M. A. & Duan, L. X. (1997). Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. American Journal of Pathology 150, 1141-1157.
14. Ganem, D. & Varmus, H. E. (1987). The molecular biology of the hepatitis B viruses. Annual Review of Biochemistry 56, 651-693.
15. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cellular Biology 119, 493-501.
16. Haviv, I., Vaizel, D. & Shaul, Y. (1996). pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO Journal 15, 3413-3420.
17. Hsu, I. C., Tokiwa, T., Bennett, W., Metcalf, R. A., Welsh, J. A., Sun, T. & Harris, C. C. (1993). p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14, 987-992.
18. Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. (1984). A short amino acid sequence able to specify nuclear location. Cell 39, 499-509.
19. Kanegae, Y., Makimura, M. & Saito, I. (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Japanese Journal of Medical Science and Biology 47, 157-166.
20. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S. & Saito, I. (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Research 23, 3816-3821.
21. Kanegae, Y., Takamori, K., Sato, Y., Lee, G., Nakai, M. & Saito, I. (1996). Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 181, 207-212.
22. Kekule, A. S., Lauer, U., Weiss, L., Luber, B. & Hofschneider, P. H. (1993). Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361, 742-745.
23. Kim, C. M., Koike, K., Saito, I., Miyamura, T. & Jay, G. (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320.
24. Kim, H., Lee, H. & Yun, Y. (1998). X-gene product of hepatitis B virus induces apoptosis in liver cells. Journal of Biological Chemistry 273, 381-385.
25. Koike, K. (1995). Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 38, 134-142.
26. Koike, K. & Takada, S. (1995). Biochemistry and functions of hepatitis B virus X protein. Intervirology 38, 89-99.
27. Koike, K., Akatsuka, T. & Miyamura, T. (1988). Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology 163, 233-235.
28. Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T. & Kurokawa, K. (1994a). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19, 810-819.
29. Koike, K., Moriya, K., Yotsuyanagi, H., Iino, S. & Kurokawa, K. (1994b). Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. Journal of Clinical Investigation 94, 44-49.
30. Koike, K., Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Tsutsumi, T. & Kimura, S. (1998). Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Cancer Letters 134, 181-186.
31. Kwee, L., Lucito, R., Aufiero, B. & Schneider, R. J. (1992). Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. Journal of Virology 66, 4382-4389.
32. Lee, T. H., Elledge, S. J. & Butel, J. S. (1995). Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. Journal of Virology 69, 1107-1114.
33. Miyazaki, J., Takaki, S., Araki, K., Tashiro, F., Tominaga, A., Takatsu, K. & Yamamura, K. (1989). Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79, 269-277.
34. Natoli, G., Avantaggiati, M. L., Chirillo, P., Puri, P. L., Ianni, A., Balsano, C. & Levrero, M. ( 1994). Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9, 2837-2843.
35. O'Brien, V. (1998). Viruses and apoptosis. Journal of General Virology 79, 1833-1845.
36. Okuda, K. (1986). Primary liver cancer. Quadrennial review lecture. Digestive Diseases and Sciences 31, 133S-146S.
37. Pan, H. & Griep, A. E. (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes & Development 8, 1285-1299.
38. Paterlini, P., Poussin, K., Kew, M., Franco, D. & Brechot, C. (1995). Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21, 313-321.
39. Seifer, M., Hohne, M., Schaefer, S. & Gerlich, W. H. (1991). In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 13, S61-S65.
40. Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M. & Koike, K. (1989). The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 80, 617-621.
41. Su, Q., Schroder, C. H., Hofmann, W. J., Otto, G., Pichlmayr, R. & Bannasch, P. (1998). Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27, 1109-1120.
42. Takada, S., Kaneniwa, N., Tsuchida, N. & Koike, K. (1997). Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15, 1895-1901.
43. Terradillos, O., Pollicino, T., Lecoeur, H., Tripodi, M., Gougeon, M. L., Tiollais, P. & Buendia, M. A. (1998). p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17, 2115-2123.
44. Tiollais, P., Pourcel, C. & Dejean, A. (1985). The hepatitis B virus. Nature 317, 489-495.
45. Twu, J. S., Lai, M. Y., Chen, D. S. & Robinson, W. S. (1993). Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192, 346-350.
46. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A. & Jay, G. (1995). Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genetics 9, 41-47.
47. Wang, X. W., Gibson, M. K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H. W., Hoeijmakers, J. H. & Harris, C. C. (1995). Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research 55, 6012-6016.
48. Williams, J. S. & Andrisani, O. M. (1995). The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proceedings of the National Academy of Sciences, USA 92, 3819-3823.
49. Yamada, T., Yamaoka, S., Goto, T., Nakai, M., Tsujimoto, Y. & Hatanaka, M. (1994). The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. Journal of Virology 68, 3374-3379.
50. Yeh, P. & Perricaudet, M. (1997). Advances in adenoviral vectors: from genetic engineering to their biology. FASEB Journal 11, 615-623.
51. Yu, D. Y., Moon, H. B., Son, J. K., Jeong, S., Yu, S. L., Yoon, H., Han, Y. M., Lee, C. S., Park, J. S., Lee, C. H., Hyun, B. H., Murakami, S. & Lee, K. K. (1999). Incidence of hepatocellular carcinoma in transgenic mice expressing hepatitis B virus X-protein. Journal of Hepatology 31, 123-132.
52. Zoulim, F., Saputelli, J. & Seeger, C. (1994). Woodchuck hepatitis virus X protein is required for viral infection in vivo. Journal of Virology 68, 2026-2030.